CN Patent
CN100577210C — 利用免疫应答系统的药物传递系统
Assigned to Ai Zhixian · Expires 2010-01-06 · 16y expired
What this patent protects
本发明的目的在于提供一种可以将抗癌剂等给药物质有效地聚集在靶向部位的药物传递组合物。本发明提供一种含有低聚糖包裹的脂质体和给药物质,用于将给药物质传送至靶向部位的药物传递脂质体组合物。
USPTO Abstract
本发明的目的在于提供一种可以将抗癌剂等给药物质有效地聚集在靶向部位的药物传递组合物。本发明提供一种含有低聚糖包裹的脂质体和给药物质,用于将给药物质传送至靶向部位的药物传递脂质体组合物。
Drugs covered by this patent
- Camptosar (Irinotecan Hydrochloride) · Pfizer
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.